Opendata, web and dolomites

LysoMod SIGNED

Genetic and Small Molecule Modifiers of Lysosomal Function

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LysoMod project word cloud

Explore the words cloud of the LysoMod project. It provides you a very rough idea of what is the project "LysoMod" about.

pharmacology    companies    dysfunction    public    participant    neurodegenerative    cross    disorder    medicine    storage    pathology    mechanisms    training    transfer    sectors    implementing    led    diseases    area    rapid    expertise    lysosomal    function    young    multidisciplinary    academic    transcriptomics    approved    trials    play    either    variety    optimize    exchange    staff    lysosomes    candidate    quality    modifier    medicinal    clinical    age    innovative    genetics    lysomod    innovate    mentored    biology    biochemistry    private    cells    generation    cell    people    therapies    drug    collaborative    careers    personalized    chemistry    disorders    genes    regulation    rnas    life    action    human    expression    lipidomics    proteomics    talk    drugs    ranging    prioritising    health    pioneer    diagnostics    lysosome    biomedical    lsd    critical    signalling    lsds    biological    gene    exploring    strategies    preparing    mouse    complementary    linked    therapeutic   

Project "LysoMod" data sheet

The following table provides information about the project.

Coordinator
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES 

Organization address
address: AVENIDA PROF EGAS MONIZ
city: LISBOA
postcode: 1649 028
website: www.imm.ul.pt

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website https://lysomod.wixsite.com/lysomod
 Total cost 1˙156˙500 €
 EC max contribution 1˙102˙500 € (95%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2016
 Funding Scheme MSCA-RISE
 Starting year 2017
 Duration (year-month-day) from 2017-03-01   to  2021-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES PT (LISBOA) coordinator 366˙300.00
2    GENOMED, DIAGNOSTICOS DE MEDICINA MOLECULAR SA PT (LISBOA) participant 240˙750.00
3    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 198˙000.00
4    INSTITUTUL DE BIOCHIMIE RO (BUCHAREST) participant 130˙500.00
5    CHRONOS BIOSYSTEMS SRL RO (Bucharest) participant 108˙000.00
6    INTRABIO LTD UK (LONDON) participant 27˙000.00
7    WEIZMANN INSTITUTE OF SCIENCE IL (REHOVOT) participant 18˙450.00
8    THE UNIVERSITY OF SUSSEX UK (BRIGHTON) participant 13˙500.00
9    FONDAZIONE TELETHON IT (ROMA) participant 0.00
10    LIPOTYPE DE (DRESDEN) participant 0.00
11    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE CL (SANTIAGO) partner 0.00
12    THE CHILDREN'S HOSPITAL OF PHILADELPHIA NON PROFIT ORG US (Philadelphia) partner 0.00
13    UNIVERSIDAD DE BUENOS AIRES AR (BUENOS AIRES) partner 0.00
14    UNIVERSIDAD DEL DESARROLLO CL (SAN CARLOS DE APOQUINDO) partner 0.00

Map

 Project objective

LysoMod will innovate in the area of personalized medicine for disorders linked to lysosomal dysfunction. This will be achieved by implementing a collaborative staff-exchange program between highly complementary and multidisciplinary academic and non-academic partners with expertise in pharmacology, medicinal chemistry, cell biology, biochemistry, mouse and human genetics, transcriptomics, proteomics and lipidomics. Based on the critical role that lysosomes play in cells, a better understanding of lysosomal function will have a major impact on human health, fostering the development of new strategies to improve quality of life for people affected by a variety of diseases, ranging from lysosomal storage diseases (LSDs) to age-related neurodegenerative disorders. LysoMod’s specific objectives are: 1) to develop and further optimize existing therapies for LSDs; 2) to identify new targets for personalized therapies for LSDs; and 3) to investigate the cross-talk between lysosomal function, signalling pathways and gene expression regulation. The pioneer work of a participant in the consortium led to the development of a drug that is approved for clinical use. LysoMod will i) investigate the mechanisms of action of this and other drugs in lysosome-related disorder; ii) identify modifier genes involved in LSD pathology and test their potential as new targets for personalized therapeutic approaches; iii) identify candidate RNAs that can be targeted to enhance lysosomal function. The companies in the consortium will ensure a rapid transfer of new knowledge into applications for diagnostics and clinical trials. Prioritising lysosomal dysfunction as a highly relevant biomedical problem, the LysoMod consortium will implement a mentored staff-exchange program to provide young researchers with high-level training in innovative approaches for exploring biological systems, preparing the next generation of researchers for careers either in the private or public health sectors.

 Deliverables

List of deliverables.
Organization of a summer school in Chile Other 2020-03-03 15:05:06
Project Website Internet-based social media Websites, patent fillings, videos etc. 2020-03-03 15:05:06

Take a look to the deliverables list in detail:  detailed list of LysoMod deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LYSOMOD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LYSOMOD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

MAIL (2019)

Identifying Marginal Lands in Europe and strengthening their contribution potentialities in a CO2sequestration strategy

Read More  

RADON (2020)

Irradiation driven nanofabrication: computational modelling versus experiment

Read More  

DisTerrMem (2019)

Memory Across Borders: Dealing with the Legacy of Disputed Territories

Read More